University of Illinois at Chicago
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Illinois at Chicago sits in the top decile of US sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count).
University of Illinois at Chicago: 430 sponsored US clinical trials, 115 recruiting.
University of Illinois at Chicago sponsors 430 registered US clinical trials on ClinicalTrials.gov, 115 of them currently recruiting, and 236 completed. 30 of these trials are in Phase 3-4 (later-stage) and 80 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Sclerosis, with 10 trials.
Top-decile sponsor footprint
University of Illinois at Chicago ranks in the top decile of sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
236 of 271 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
430 total, page 5 of 9
Multi-Omics Study of the Effect and Mechanisms of Acupuncture on Psychoneurological Symptoms Among Breast Cancer Survivors
NCT05417451
Hydration Dynamics and Influence of Beverage Composition
NCT05111392
TRE With Physical Activity for Weight Management
NCT04978376
Perceived Social Support, Heart Rate Variability, and Hopelessness in Patients With Ischemic Heart Disease
NCT05003791
A Dissonance-Based Obesity Intervention
NCT04068493
Remotely Supervised tDCS for Slowing ALS Disease Progression
NCT04866771
Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline
NCT04682977
Feasibility Trial of the TELL Tool Intervention
NCT04841967
Evaluation of the Wits Workout Wellness Program for Older Adults
NCT04928885
Retrospective/Prospective Study of Pediatric Surgical Patients
NCT04899557
Study of a PST-Trained Voice-Enabled Artificial Intelligence Counselor (SPEAC) for Adults With Emotional Distress (Phase 1)
NCT04524104
Reward and Drug Effects on Mood and Brain Response
NCT04512365
A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney Disease
NCT04335721
Building Financial Wellness Randomized Controlled Trial
NCT06489275
Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells
NCT04626583
CogXergaming to Promote Physical Activity and Cognitive Function in Frail Older Adults
NCT04534686
Time Restricted Eating for Weight Management
NCT04692532
The Effect of Music on Colonoscopy (MUSICOL)
NCT04628052
A Physical Activity Program to Disrupt Sedentary Time in Older Latinos
NCT04507464
Effect of Oral Curcumin Supplementation in Dry Age-related Macular Degeneration (AMD) Patients
NCT04590196
Implementation of Electronic Shared Decision-Making Support for Early Intervention
NCT04562038
Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach
NCT04112368
Papuan Indigenous Model of Male Circumcision
NCT06212531
Mimic-game & Groove: A TeleXercise Intervention to Get Active & Get Healthy
NCT05134870
Angiotensin II in the Perioperative Management of Hypotension in Kidney Transplant Recipients
NCT04529005
Improving Cancer Survival and Reducing Treatment Variations With Protocols for Emergency Care
NCT04673890
Online Intervention to Prevent Perinatal Depression and Promote Breastfeeding
NCT04128202
HealthMatters@24/7 eLearning for People Supporting Adults With Intellectual and Developmental Disabilities
NCT03206164
An Avatar-based Mobile Phone Intervention to Promote Health in African American MSM
NCT04217174
An Innovative Mobile Health Intervention to Improve Self-care in Patients With Heart Failure
NCT04262544
Real-world Evaluation of Bezlotoxumab for the Management of Clostridioides Difficile Infection
NCT04317963
Does a Video-based Education Tool Related to Strengthening Result in Different Functional Outcomes Compared to Traditional Physical Therapy Education for Patients?
NCT04245852
Sit Down and Play India
NCT04167254
Effect of Mouthwashes on Oral Wound Healing and Microbiome
NCT05270382
The Impact of a Resistance Training Intervention on Blood Pressure Control in Older Adults With Sarcopenia
NCT04255745
Acupuncture for Adults With Sickle Cell Disease (SCD): A Feasibility Study
NCT04156399
Cancer Screening; Access; Awareness; Navigation
NCT04131946
Evaluating the Impact of Focused Muscle Contraction Therapy in Retire APF Players
NCT04822311
Premenstrual Hormonal and Affective State Evaluation (PHASE) Project
NCT03862469
Transfemoral Socket Design and Muscle Function
NCT04212299
Zepatier in Patients with Substance Use
NCT04048850
Building Self-regulation Capacity in AA T2DM Women: Feasibility of EMI
NCT04083248
Community Health Worker Intervention to Improve Post-Hospital Outcomes
NCT04028609
Alternate Day Fasting, Exercise, and NAFLD
NCT04004403
CATER: Comprehensive Alveolar and Tooth Esthetic Replacement
NCT04082143
The Role of Virtual Reality in Orthopaedic Surgery Education
NCT04302298
Reducing Hopelessness Through Improved Physical Activity in Adults With Heart Disease: With COVID-19 Considerations
NCT03907891
Comparison of Articaine Mandibular Infiltration to Lidocaine Inferior Alveolar Nerve Block in Pediatric Patients
NCT04865848
Prostate Cancer Detection Screening MRI Protocol
NCT04175730
Acupuncture for Individuals With Stable Angina
NCT02914834
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 37 |
| Phase 2 | 43 |
| Phase 3 | 11 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the University of Illinois at Chicago pipeline
115 recruiting of 430 indexed (27% open); 236 completed (55%).
Phase mix: 30 late (III/IV) vs 80 early (I/II) (early-phase heavy).
Top condition: Multiple Sclerosis (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Illinois at Chicago: open-pipeline peers nationwide
Peers matched on 430 registered trials and 27% open enrollment, not the therapeutic-area sidebar.
University of Illinois at Chicago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 430 trials (± recruiting share)
- Vanderbilt University · 430 trials · 3% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
- Novo Nordisk A/S · 431 trials · 8% recruiting
- Dartmouth-Hitchcock Medical Center · 427 trials · 12% recruiting
Sponsors near 27% open enrollment (± trial volume)
- Coherus Oncology · 27% recruiting · 15 trials
- NewAmsterdam Pharma · 27% recruiting · 15 trials
- Portland VA Medical Center · 27% recruiting · 15 trials
- White River Junction Veterans Affairs Medical Center · 27% recruiting · 15 trials
Related
What to do with this University of Illinois at Chicago page
430 registered trials is a research-attention snapshot, not an endorsement of University of Illinois at Chicago or any single study.
- 115 of University of Illinois at Chicago's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Multiple Sclerosis is the condition University of Illinois at Chicago studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Sclerosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Illinois at Chicago pipeline card: 430 registered trials from official public datasets.Report a data error.